Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

ESG Focus: Top ASX Companies, Superbugs & Hydrogen

Feb 07 2025 - ESG Focus

Addressing challenges and opportunities in meeting the UN Sustainable Development Goals and what ESG characteristics underpin share prices


Amcor Confident In Berry On Top

Feb 07 2025 - Australia

Amcor posted a solid quarter but all eyes are on the company’s proposed takeover of the larger Berry Global Group


FNArena Corporate Results Monitor – 06-02-2025

Feb 06 2025 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments


FNArena Corporate Results Monitor – 05-02-2025

Feb 05 2025 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments


Technical Views On Nasdaq, ASX200 & Oil

Feb 05 2025 - Technicals

Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil


January In Review: Record High For The ASX200

Feb 05 2025 - Australia

Gains across consumer discretionary and financials helped the ASX200 outperform international equities and record a 4.6% gain in January, but tariff uncertainty clouds the outlook


ResMed Shakes Off GLP-1 Scare

Feb 04 2025 - Australia

The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a positive for the sleep apnoea industry


JB Hi-Fi’s Uptrend Continues

Feb 04 2025 - Technicals

Michael Gable of Fairmont Equities sees the rally in JB Hi-Fi shares continuing


Doubts & Worries Dominate Kogan’s Outlook

Feb 03 2025 - Small Caps

Earnings for Kogan.com missed expectations in the second quarter and most analysts do not share Canaccord Genuity’s optimism


Perpetual: Closing The Gap

Feb 03 2025 - Technicals

On Friday, The Chartist expressed a cautiously positive tone regarding price action in Perpetual shares


Analyse The Market From A Different Angle